ZA200805905B - Use of soluble dietary fibres against muscle wasting - Google Patents

Use of soluble dietary fibres against muscle wasting

Info

Publication number
ZA200805905B
ZA200805905B ZA200805905A ZA200805905A ZA200805905B ZA 200805905 B ZA200805905 B ZA 200805905B ZA 200805905 A ZA200805905 A ZA 200805905A ZA 200805905 A ZA200805905 A ZA 200805905A ZA 200805905 B ZA200805905 B ZA 200805905B
Authority
ZA
South Africa
Prior art keywords
muscle wasting
soluble dietary
dietary fibres
units
against muscle
Prior art date
Application number
ZA200805905A
Other languages
English (en)
Inventor
Gorselink Marchel
Van Helvoort Adrianus Lambertus Bertholdus
Hageman Robert Johan Joseph
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36028309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200805905(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of ZA200805905B publication Critical patent/ZA200805905B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/729—Agar; Agarose; Agaropectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pediatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
ZA200805905A 2005-12-16 2006-12-18 Use of soluble dietary fibres against muscle wasting ZA200805905B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05112336 2005-12-16

Publications (1)

Publication Number Publication Date
ZA200805905B true ZA200805905B (en) 2009-10-28

Family

ID=36028309

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805905A ZA200805905B (en) 2005-12-16 2006-12-18 Use of soluble dietary fibres against muscle wasting

Country Status (17)

Country Link
US (2) US8143235B2 (pl)
EP (1) EP1965669B1 (pl)
JP (1) JP2009519328A (pl)
CN (2) CN102948659B (pl)
AT (1) ATE441333T1 (pl)
AU (1) AU2006325591B2 (pl)
BR (1) BRPI0619947B1 (pl)
CA (1) CA2633292C (pl)
DE (1) DE602006008985D1 (pl)
DK (1) DK1965669T3 (pl)
ES (1) ES2332149T3 (pl)
IL (1) IL192219A (pl)
NZ (1) NZ569169A (pl)
PL (1) PL1965669T3 (pl)
RU (1) RU2450815C2 (pl)
WO (1) WO2007069900A1 (pl)
ZA (1) ZA200805905B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
CN102131405B (zh) * 2008-06-19 2014-06-11 纽迪希亚公司 用于减肥手术患者的液体营养组合物
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
CN102170792A (zh) * 2008-07-18 2011-08-31 希尔氏宠物营养品公司 提高老龄动物生活质量的方法
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
MX2013012228A (es) * 2011-04-18 2013-12-06 Nestec Sa Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas.
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
ES2402643B1 (es) 2012-12-24 2014-01-24 Universitat De Lleida Combinación de fibra anticolesterolémica
EP3166981A4 (en) 2014-07-09 2018-03-07 Cadena Bio, Inc. Oligosaccharide compositions and methods for producing thereof
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
EP3285777B1 (en) 2015-04-23 2021-06-09 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2017178315A1 (en) * 2016-04-14 2017-10-19 Dupont Nutrition Biosciences Aps Bifidobacteria for increasing lean body mass
CN106387923B (zh) * 2016-09-07 2019-12-20 中国农业大学 一种富含半乳甘露聚糖的可溶性膳食纤维及其制备方法
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
DE102017201713A1 (de) * 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
KR20210135215A (ko) * 2018-11-08 2021-11-12 디에스엠 아이피 어셋츠 비.브이. 위장 항상성 유지를 지원하는 방법
EP3876749B1 (en) * 2018-11-08 2024-02-14 DSM IP Assets B.V. Methods of selectively modulating gastrointestinal microbial growth
EP3975755A1 (en) * 2019-05-24 2022-04-06 Cosucra Groupe Warcoing S.A. Composition comprising inulin and protein

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
NZ334021A (en) * 1996-08-09 2001-01-26 Mannatech Inc Dietary supplement containing at least two saccharides being the building blocks of glycoproteins
US5776524A (en) 1996-10-30 1998-07-07 The Iams Company Process for treating small intestine bacterial overgrowth in animals
US5817695A (en) 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
GB2364642B (en) * 2000-01-07 2004-10-27 Bioenergy Inc Compositions for enhancing the immune response
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
JP2003137790A (ja) * 2001-11-01 2003-05-14 Mie Kariyou Kk β−２，１（β２→β１）結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
JP2004051942A (ja) * 2002-05-29 2004-02-19 Daicel Chem Ind Ltd 分散体及びそれを用いた成形体の製造方法
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
DK1643861T3 (da) * 2003-07-15 2011-07-25 Nestec Sa Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
EP2123282A3 (en) 2003-10-24 2010-01-20 N.V. Nutricia Immunemodulating oligosaccharides
DE602006015042D1 (de) * 2005-04-21 2010-08-05 Nutricia Nv Nahrungsergänzungsmittel für hiv-patienten
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
WO2007069900A1 (en) 2007-06-21
US8143235B2 (en) 2012-03-27
IL192219A (en) 2011-08-31
DE602006008985D1 (de) 2009-10-15
NZ569169A (en) 2012-01-12
IL192219A0 (en) 2008-12-29
CN101374426A (zh) 2009-02-25
PL1965669T3 (pl) 2010-02-26
ES2332149T3 (es) 2010-01-27
EP1965669B1 (en) 2009-09-02
CN102948659A (zh) 2013-03-06
DK1965669T3 (da) 2009-10-05
US20090203573A1 (en) 2009-08-13
RU2450815C2 (ru) 2012-05-20
BRPI0619947B1 (pt) 2023-10-10
CA2633292A1 (en) 2007-06-21
AU2006325591B2 (en) 2012-07-12
EP1965669A1 (en) 2008-09-10
CN102948659B (zh) 2014-04-23
AU2006325591A1 (en) 2007-06-21
CN101374426B (zh) 2012-11-28
US9555059B2 (en) 2017-01-31
US20120165243A1 (en) 2012-06-28
CA2633292C (en) 2015-04-28
ATE441333T1 (de) 2009-09-15
BRPI0619947A2 (pt) 2011-10-25
JP2009519328A (ja) 2009-05-14
RU2008129102A (ru) 2010-01-27

Similar Documents

Publication Publication Date Title
ZA200805905B (en) Use of soluble dietary fibres against muscle wasting
PL1841332T3 (pl) Kompozycja zagęszczacza dla pacjentów z trudnością połykania
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
MXPA05010873A (es) Metodos para el tratamiento de enfermedad de parkinson.
SI2046378T1 (sl) Uporaba bakterijskih polisaharidov za inhibicijo biofilma
MY148405A (en) Immunogenic composition
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2007109069A3 (en) Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof
IL172631A0 (en) Gaboxadol for treating depression and other affective disorders
ATE461780T1 (de) Werkzeugmaschinenkartusche
PL1965809T3 (pl) Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
BR0115177A (pt) Prevenção de fixação bacteriana em biomateriais por polissacarìdeos catiÈnicos
NZ530037A (en) Use of glycosaminoglycans for the treatment of HIV-associated nephropathy
PT1643861E (pt) Composição nutricional líquida rica em fibras alimentares e rica em calorias para a saúde intestinal no doente idoso
BRPI0717458A2 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional.
EP2082082A4 (en) MULTICOMPONENT FIBERS CONTAINING HIGH CHAIN LENGTH POLYAMIDES
MY139498A (en) Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
BRPI0506466A (pt) composição alimentìcia pobre em carboidratos e método para fabricar uma composição alimentìcia
EP0989226A3 (en) Water based fiber treatment agent
HK1074582A1 (en) Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
PT1641875E (pt) Composi??o amil?cea cati?nica l?quida e suas utiliza??es
ATE518544T1 (de) Rotbusch-extrakt gegen diabetes
UA97359C2 (en) Immunogenic composition